The pathogenesis of IgG4-RD assumes the increased activity of T regulatory cells with overexpression of IL-10, production of transforming growth factor-β, and upregulation of Th2 response, in which interleukins 4, 5, and 13 play predominant roles. The gene discussed is IL10; the disease is immunoglobulin G4-related sclerosing disease.